Semaglutide

Also known as: Ozempic

How it works
Side Effects
Disclaimer

Semaglutide is a medication used in the treatment of type 2 diabetes and obesity. It belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Semaglutide works by mimicking the actions of the naturally occurring hormone glucagon-like peptide-1 (GLP-1) in the body.

Here’s how Semaglutide works:

1. Stimulation of Insulin Release: Semaglutide stimulates the release of insulin from the pancreas in response to elevated blood sugar levels. Insulin helps to lower blood sugar levels by facilitating the uptake of glucose by cells, particularly in muscles and the liver.

2. Inhibition of Glucagon Release: Glucagon is a hormone produced by the pancreas that raises blood sugar levels by promoting the release of glucose from the liver. Semaglutide helps inhibit the release of glucagon, thereby reducing the amount of glucose released into the bloodstream.

3. Slowing Gastric Emptying: Semaglutide slows down the rate at which food moves through the stomach and into the small intestine. This delay in gastric emptying helps to reduce the rapid rise in blood sugar levels that typically occurs after eating.

4. Promotion of Satiety: Semaglutide can also act on the brain to reduce appetite, leading to decreased food intake and potential weight loss. This effect is particularly beneficial for individuals with type 2 diabetes who are overweight or obese.

By combining these effects—stimulating insulin release, inhibiting glucagon release, slowing gastric emptying, and promoting satiety—Semaglutide helps to improve glycemic control, reduce blood sugar levels, and potentially aid in weight loss in people with type 2 diabetes and obesity. It is typically administered as a subcutaneous injection and is used in conjunction with diet and exercise to effectively manage these conditions.

Semaglutide, like any medication, can cause side effects in some individuals. Common side effects of semaglutide may include:

1. Nausea: Nausea is one of the most common side effects reported with semaglutide use, especially when initiating treatment. This symptom may improve over time for some individuals.

2. Vomiting: Some people may experience vomiting as a side effect of semaglutide, particularly during the initial stages of treatment.

3. Diarrhea: Diarrhea is another gastrointestinal side effect that may occur with semaglutide use. It may resolve on its own or with adjustments in dosage.

4. Constipation: While less common than diarrhea, some individuals may experience constipation as a side effect of semaglutide.

5. Abdominal Pain: Pain or discomfort in the abdominal region is another potential side effect of semaglutide.

6. Hypoglycemia: Semaglutide, like other GLP-1 receptor agonists, can lower blood sugar levels. In some cases, this may lead to hypoglycemia (low blood sugar), especially when used in combination with other medications that lower blood sugar levels.

7. Injection Site Reactions: Semaglutide is administered as a subcutaneous injection, which can sometimes cause injection site reactions such as redness, swelling, or itching.

8. Pancreatitis: Rarely, Semaglutide may increase the risk of pancreatitis, an inflammation of the pancreas. Symptoms of pancreatitis include severe abdominal pain, nausea, and vomiting. If these symptoms occur, medical attention should be sought immediately.

9. Thyroid Tumors: There have been reports of thyroid tumors, including thyroid cancer, in animal studies with Semaglutide. However, it is not clear if the same risk exists in humans.

It’s important to note that not everyone will experience these side effects, and some individuals may experience different or no side effects at all. Additionally, if you experience any concerning or severe side effects while taking Semaglutide, it’s essential to consult your healthcare provider for guidance. They can provide personalized advice and may adjust your treatment regimen if necessary.

The following information is for informational purposes only and should not be considered medical advice. It is important to consult with a healthcare professional or pharmacist for specific guidance on medications. Additionally, the side effects and precautions mentioned here are not exhaustive, and individuals should refer to the medication package insert or consult with a healthcare provider for comprehensive information regarding Semaglutide.

*Pricing is subject to change with dosage increase.

Tirzepatide

Also known as: Wegovy

How it works
Side Effects
Disclaimer

Tirzepatide is a novel drug used in the treatment of type 2 diabetes and medically supervised weight loss. It belongs to a class of medications known as incretin mimetics. It works by mimicking the actions of two naturally occurring hormones in the body called glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP).

Here’s how Tirzepatide works:

1. Stimulation of Insulin Release: Tirzepatide stimulates the release of insulin from the pancreas in response to elevated blood sugar levels. Insulin helps to lower blood sugar levels by facilitating the uptake of glucose by cells, especially in muscles and the liver.

2. Inhibition of Glucagon Release: Glucagon is a hormone produced by the pancreas that raises blood sugar levels by promoting the release of glucose from the liver. Tirzepatide helps inhibit the release of glucagon, thereby reducing the amount of glucose released into the bloodstream.

3. Slowing Gastric Emptying: Tirzepatide slows down the rate at which food moves through the stomach and into the small intestine. This delay in gastric emptying helps to reduce the rapid rise in blood sugar levels that typically occurs after eating.

4. Suppressing Appetite: Tirzepatide can also act on the brain to reduce appetite, leading to decreased food intake and potential weight loss. This effect is particularly beneficial for individuals with type 2 diabetes who are overweight or obese.

By combining the effects of stimulating insulin release, inhibiting glucagon release, slowing gastric emptying, and suppressing appetite, tirzepatide helps to improve glycemic control, reduce blood sugar levels, and promote weight loss in people with type 2 diabetes. It is administered as a subcutaneous injection and is typically used in conjunction with diet and exercise to manage diabetes effectively.

As with any medication, Tirzepatide can cause side effects, although not everyone will experience them.

Some common side effects of Tirzepatide may include:

1. Gastrointestinal Issues: These may include nausea, vomiting, diarrhea, constipation, abdominal pain, and indigestion. These side effects usually diminish over time as the body adjusts to the medication.

2. Hypoglycemia: Tirzepatide, like other medications used to treat diabetes, can sometimes cause low blood sugar (hypoglycemia). Symptoms of hypoglycemia include sweating, shakiness, dizziness, hunger, confusion, irritability, and rapid heartbeat. It’s important to monitor blood sugar levels closely and be prepared to treat hypoglycemia if it occurs.

3. Injection Site Reactions: Some people may experience redness, itching, swelling, or pain at the site of injection.

4. Pancreatitis: In rare cases, tirzepatide can cause inflammation of the pancreas (pancreatitis), which may lead to severe abdominal pain, nausea, vomiting, and fever. If you experience these symptoms, seek medical attention immediately.

5. Thyroid Tumors: There is a potential risk of thyroid tumors with tirzepatide, particularly in rodents. However, it’s essential to note that the relevance of this finding to humans is not fully understood.

6. Hypersensitivity Reactions: Some individuals may experience allergic reactions to tirzepatide, which can manifest as rash, itching, swelling, or difficulty breathing. Seek medical attention if you experience any signs of an allergic reaction.

7. Kidney Problems: There have been reports of kidney problems, including worsening kidney function and acute kidney injury, associated with Tirzepatide use. Monitoring kidney function is recommended, especially in individuals with pre-existing kidney issues.

It’s essential to discuss any concerns or potential side effects with your healthcare provider before starting Tirzepatide or any other medication. They can provide guidance on managing side effects and determine whether Tirzepatide is an appropriate treatment option for you.

The following information is for informational purposes only and should not be considered medical advice. It is important to consult with a healthcare professional or pharmacist for specific guidance on medications. Additionally, the side effects and precautions mentioned here are not exhaustive, and individuals should refer to the medication package insert or consult with a healthcare provider for comprehensive information regarding Tirzepatide.

*Pricing is subject to change with dosage increase.

If deemed medically ineligible, send us an email and we will refund your payment

Ready to see a change?

Size Matters Now - Now Serving:

Semaglutide

Semaglutide is a medication used in the treatment of type 2 diabetes and obesity. It belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Semaglutide works by mimicking the actions of the naturally occurring hormone glucagon-like peptide-1 (GLP-1) in the body.

Here’s how Semaglutide works:

1. **Stimulation of Insulin Release**: Semaglutide stimulates the release of insulin from the pancreas in response to elevated blood sugar levels. Insulin helps to lower blood sugar levels by facilitating the uptake of glucose by cells, particularly in muscles and the liver.

2. **Inhibition of Glucagon Release**: Glucagon is a hormone produced by the pancreas that raises blood sugar levels by promoting the release of glucose from the liver. Semaglutide helps inhibit the release of glucagon, thereby reducing the amount of glucose released into the bloodstream.

3. **Slowing Gastric Emptying**: Semaglutide slows down the rate at which food moves through the stomach and into the small intestine. This delay in gastric emptying helps to reduce the rapid rise in blood sugar levels that typically occurs after eating.

4. **Promotion of Satiety**: Semaglutide can also act on the brain to reduce appetite, leading to decreased food intake and potential weight loss. This effect is particularly beneficial for individuals with type 2 diabetes who are overweight or obese.

Semaglutide, like any medication, can cause side effects in some individuals. Common side effects of semaglutide may include:

1. **Nausea**: Nausea is one of the most common side effects reported with semaglutide use, especially when initiating treatment. This symptom may improve over time for some individuals.

2. **Vomiting**: Some people may experience vomiting as a side effect of semaglutide, particularly during the initial stages of treatment.

3. **Diarrhea**: Diarrhea is another gastrointestinal side effect that may occur with semaglutide use. It may resolve on its own or with adjustments in dosage.

4. **Constipation**: While less common than diarrhea, some individuals may experience constipation as a side effect of semaglutide.

5. **Abdominal Pain**: Pain or discomfort in the abdominal region is another potential side effect of semaglutide.

6. **Hypoglycemia**: Semaglutide, like other GLP-1 receptor agonists, can lower blood sugar levels. In some cases, this may lead to hypoglycemia (low blood sugar), especially when used in combination with other medications that lower blood sugar levels.

7. **Injection Site Reactions**: Semaglutide is administered as a subcutaneous injection, which can sometimes cause injection site reactions such as redness, swelling, or itching.

8. **Pancreatitis**: Rarely, Semaglutide may increase the risk of pancreatitis, an inflammation of the pancreas. Symptoms of pancreatitis include severe abdominal pain, nausea, and vomiting. If these symptoms occur, medical attention should be sought immediately.

9. **Thyroid Tumors**: There have been reports of thyroid tumors, including thyroid cancer, in animal studies with Semaglutide. However, it is not clear if the same risk exists in humans.